Cargando…
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
As the progression of low-grade diffuse astrocytomas into grade 4 tumors significantly impacts patient prognosis, a better understanding of this process is of paramount importance for improved patient care. In this project, we analyzed matched IDH-mutant astrocytomas before and after progression to...
Autores principales: | Rautajoki, Kirsi J., Jaatinen, Serafiina, Hartewig, Anja, Tiihonen, Aliisa M., Annala, Matti, Salonen, Iida, Valkonen, Masi, Simola, Vili, Vuorinen, Elisa M., Kivinen, Anni, Rauhala, Minna J., Nurminen, Riikka, Maass, Kendra K., Lahtela, Sirpa-Liisa, Jukkola, Arja, Yli-Harja, Olli, Helén, Pauli, Pajtler, Kristian W., Ruusuvuori, Pekka, Haapasalo, Joonas, Zhang, Wei, Haapasalo, Hannu, Nykter, Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629206/ https://www.ncbi.nlm.nih.gov/pubmed/37932833 http://dx.doi.org/10.1186/s40478-023-01669-9 |
Ejemplares similares
-
PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas
por: Rautajoki, Kirsi J., et al.
Publicado: (2022) -
Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017) -
Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives
por: Alanen, Eljas, et al.
Publicado: (2023) -
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017) -
Simulation of microarray data with realistic characteristics
por: Nykter, Matti, et al.
Publicado: (2006)